New clinical data from Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSXV:MDNA) is strengthening confidence in its lead cancer therapy, positioning the company as a notable player in the next wave of immuno-oncology treatments. On April 28, the company received a Speculative Buy rating and a C$3.75 12-month price target from Research […]
Raymond James bullish rating for Bausch Health Companies (Bausch Health Companies NAME Stock Quote, Chart, News, Analysts, Financials NYSE:BHC) remains unchanged after a U.S. District Court ruling on April 17, which granted summary judgment in favour of Bausch Health and Teva, denying Norwich Pharmaceuticals’ attempt to launch a generic version of Xifaxan before January 2028. […]
Share
Tweet
Share
